Promentis Pharmaceuticals' Grant

Promentis Pharmaceuticals raised a round of funding on August 16, 2008. Investors include National Institutes of Health.

Promentis Pharmaceuticals is a pharmaceutical company developing compounds for the treatment of schizophrenia and other central nervous system disorders. Promentis' drug development efforts are focuse…

Articles about Promentis Pharmaceuticals' Grant: